AAV2/8.TBG.hARSB

N/A

Report date: 2023/10/26 16:56:37

Base Information

Drug NameAAV2/8.TBG.hARSB
Drug Alias NameAAV2/8.TBG.hARSB (Fondazione Telethon)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV2/8 vector
Mechanisms of ActionArylsulfatase B gene transference
TargetsArylsulfatase B
Therapy Area/IndicationsMucopolysaccharidosis VI
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesFondazione Telethon
China Registration ClassN/A

Develop Information

Active CompaniesFondazione Telethon
Inactive CompaniesN/A
Active IndicationsMucopolysaccharidosis VI
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A